ml 7 has been researched along with Fatty Liver in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Li, J | 1 |
| Chi, Y | 1 |
| Li, M | 1 |
| Pan, X | 1 |
| Zhang, Q | 1 |
| He, X | 1 |
| Liu, Y | 1 |
1 other study available for ml 7 and Fatty Liver
| Article | Year |
|---|---|
[Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model].
Topics: Animals; Azepines; Disease Models, Animal; Fatty Liver; Interleukin-6; Intestinal Mucosa; Intestines | 2015 |